71 related articles for article (PubMed ID: 1509190)
1. [Sequential administration of a reduced dose of almitrine to patients with chronic obstructive bronchopneumopathies. A controlled multicenter study].
Weitzenblum E; Arnaud F; Bignon J; Boutin C; Brune J; Castaing Y; Courty G; Derenne J; Duroux P; Fréour P
Rev Mal Respir; 1992; 9(4):455-63. PubMed ID: 1509190
[TBL] [Abstract][Full Text] [Related]
2. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
4. [Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
Nowak D; Wywiol A; Magnussen H
Pneumologie; 1998 Mar; 52(3):121-7. PubMed ID: 9564184
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
[TBL] [Abstract][Full Text] [Related]
6. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
Sadoul P
Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
[TBL] [Abstract][Full Text] [Related]
7. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
8. Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
Pinet C; Tessonnier F; Ravel T; Orehek J
Respir Med; 2001 Jul; 95(7):602-5. PubMed ID: 11453318
[TBL] [Abstract][Full Text] [Related]
9. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
Seignalet C; Préfaut C; Gonzales C; Michel FB
Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
[TBL] [Abstract][Full Text] [Related]
11. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
[TBL] [Abstract][Full Text] [Related]
12. [Neuropathies and almitrine. 14 cases].
Petit H; Leys D; Hurtevent JF; Parent M; Caron J; Salomez JL; Krivosic I
Rev Neurol (Paris); 1987; 143(6-7):510-9. PubMed ID: 2889253
[TBL] [Abstract][Full Text] [Related]
13. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Weitzenblum E; Schrijen F; Apprill M; Prefaut C; Yernault JC
Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
[TBL] [Abstract][Full Text] [Related]
14. [Combination of thiotropium bromide with almitrine and pulmonary rehabilitation in the treatment of patients with chronic obstructive pulmonary disease].
Titova ON; Ignat'ev VA; Didur MD; Kameneva MIu; Sukhovskaia OA
Ter Arkh; 2008; 80(3):28-33. PubMed ID: 18441680
[TBL] [Abstract][Full Text] [Related]
15. Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction.
De Backer W; Vermeire P; Bogaert E; Janssens E; Van Maele R
Bull Eur Physiopathol Respir; 1985; 21(5):427-32. PubMed ID: 3904873
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
[TBL] [Abstract][Full Text] [Related]
18. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
[TBL] [Abstract][Full Text] [Related]
19. [Long-term therapy with almitrine dimesilate has no effect on pulmonary hemodynamics at rest and during stress].
Böhning W; Winkelmann B; Worth H; Wettengel R; Brüch M; Breuer HW; Müller-Höhl ML; Nikolaus J
Pneumologie; 1990 Feb; 44 Suppl 1():444-5. PubMed ID: 2114628
[TBL] [Abstract][Full Text] [Related]
20. [The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention].
Xu FP; Cai YY; Niu SF
Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):479-81, 511. PubMed ID: 2128259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
